Rinaldi Convalescent Hospital: Blood Thinner Monitoring Failure - CA

Nobody had a physician's order to monitor them. Nobody checked.

The resident, identified in inspection records only as Resident 99, was admitted to the facility at 16553 Rinaldi Street on March 25, 2026, with a urinary tract infection, difficulty swallowing, and a urinary tract obstruction that caused urine to flow backward into the kidneys. A physician's history and physical, completed two days after admission, documented that the resident lacked the capacity to make medical decisions for themselves.

Also on the day of admission, a physician ordered enoxaparin sodium, a blood thinner injected under the skin every 24 hours, to prevent deep vein thrombosis. Blood clots forming in the deep veins of the legs are a serious and common risk for patients who are not moving around. The drug was the right call for that risk. What happened next was not.

Medication records show the facility administered enoxaparin injections to Resident 99 on March 26 and March 27. The same records contain no documentation of any monitoring for bleeding or bruising on either day. No nurse checked. No physician order existed directing anyone to check. The facility's own anticoagulation policy, reviewed and updated as recently as January 29, 2026, required exactly that monitoring.

The gap between what the policy said and what staff did was not subtle or technical. It was a complete absence.

When an inspector sat down with the Assistant Director of Nursing on the evening of March 28, the records made the problem plain. The ADON reviewed Resident 99's physician order summary and March medication administration record alongside the inspector. The ADON stated that the order summary contained no physician order to monitor for bleeding or bruising as a side effect of enoxaparin. The ADON stated licensed staff had not obtained such an order. The ADON stated licensed staff are required to obtain a physician order to monitor residents on anticoagulants for side effects, to ensure residents do not experience bleeding. And then the ADON stated what the record already showed: licensed staff did not monitor Resident 99 for the side effects of enoxaparin sodium. The potential outcome, the ADON said, was to cause bleeding.

That last part is worth sitting with. The facility's own nursing leadership described the foreseeable consequence of what their staff failed to do.

The Director of Nursing, interviewed the following afternoon on March 29, confirmed the same understanding. Residents receiving anticoagulants should be monitored for bleeding, the DON said, because bleeding is a known side effect of these medications. Resident 99 was prescribed enoxaparin, the DON said, and monitoring for bleeding during its use was important to ensure any bleeding would be identified and addressed.

Enoxaparin belongs to a class of drugs that work precisely because they interfere with the blood's ability to clot. That is the mechanism that makes them effective against deep vein thrombosis. It is also the mechanism that makes undetected bleeding dangerous. Internal bleeding, blood in the urine, unusual bruising, bleeding that does not stop — these are the signals that tell a clinician the drug is doing more than intended. Without monitoring, those signals go unread. A resident who cannot make medical decisions for themselves and cannot reliably report their own symptoms depends entirely on nursing staff to catch what they cannot describe.

Resident 99's own facility policy spelled out the response protocol for exactly this scenario. If a resident on anticoagulation therapy shows signs of excessive bruising, blood in the urine, or any other evidence of bleeding, the policy states, the nurse will discuss the situation with the physician before giving the next scheduled dose. The policy assumed monitoring would happen. Monitoring did not happen.

The inspection was conducted on March 29, 2026, and the deficiency was cited under federal standards governing unnecessary medications, which cover drugs administered in excessive doses, for excessive duration, or without adequate monitoring. The harm level was classified as minimal harm with potential for more serious consequences, a designation that reflects what actually occurred versus what could have occurred. The inspection report states explicitly that the deficient practice had the potential for Resident 99 to experience serious adverse consequences, possibly resulting in bleeding, hospitalization, or death.

Minimal harm is the floor. Bleeding, hospitalization, or death is the ceiling. For a resident who arrived four days before the inspection with a urinary tract infection and no capacity to speak for themselves about how they were feeling, the distance between those two outcomes was a nursing staff that either checked or didn't.

They didn't.

What the inspection record does not contain is any indication of whether Resident 99 experienced bleeding during those two days. The records reviewed by the inspector documented the absence of monitoring, not the presence or absence of harm. That distinction matters, and it also has limits. Monitoring exists because harm is not always visible without it. Blood in the urine, for a resident with an existing urinary tract infection and urinary tract obstruction, could be attributed to the underlying condition. Bruising on a resident who is not ambulatory might not be noticed without a deliberate check. The point of monitoring is to find what would otherwise be missed.

The facility's anticoagulation protocol was not a new document. It had been reviewed less than two months before Resident 99's admission. The policy existed. The staff knew what it required. The ADON confirmed that staff are required to obtain a physician order for monitoring. None of that translated into action for this resident.

Rinaldi Convalescent Hospital has been a licensed skilled nursing facility in the Granada Hills neighborhood of Los Angeles for decades. The inspection that produced this citation was a standard health survey. The single deficiency cited involved one resident over a span of two days. By the metrics used to rank nursing home violations, this was not a sprawling systemic failure across dozens of patients. It was one resident, two injections, no monitoring order, no monitoring.

For Resident 99, who came through the door already unable to make decisions about their own care, already managing multiple diagnoses, already dependent on the staff around them to catch what they could not catch themselves, the narrowness of the violation is not a comfort. It is the whole story.

The facility's plan of correction was not included in the inspection documents reviewed for this report.

Full Inspection Report

The details above represent a summary of key findings. View the complete inspection report for Rinaldi Convalescent Hospital from 2026-03-29 including all violations, facility responses, and corrective action plans.

Additional Resources

• View all inspection reports for Rinaldi Convalescent Hospital
• Browse all CA nursing home inspections